Fate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	39.57	46.63	36.06	41.87	61.33	133.58
Short-Term Investments	135.25	157.03	243.01	273.31	374.89	482.33
Cash & Short-Term Investments	174.82	203.66	279.07	315.18	436.23	615.91
Cash Growth	-27.29%	-27.02%	-11.46%	-27.75%	-29.17%	27.54%
Accounts Receivable	0.7	0.92	3.54	1.83	38.48	8.68
Other Current Assets	4	4.13	9.3	14.54	27.37	8.83
Total Current Assets	179.53	208.7	291.91	331.54	502.07	633.41
Net Property, Plant & Equipment	95.34	98.53	110.89	158.51	176.09	162.25
Long-Term Investments	-	1.47	27.66	0.98	4.94	100.66
Other Long-Term Assets	10.05	10.23	10.24	15.19	22.46	25.13
Total Assets	284.92	318.94	440.69	506.22	705.56	921.46
Accounts Payable	3.28	2.66	9.37	4.72	8.27	8.61
Accrued Expenses	13.64	20.02	21.35	27.51	53.93	42.41
Current Portion of Leases	4.74	4.56	7.42	6.18	5.63	5.58
Unearned Revenue	0.58	0.38	0.39	0.69	42.23	48.61
Other Current Liabilities	8.45	8.45	-	-	4	3.2
Total Current Liabilities	30.69	36.07	38.52	39.09	114.05	81.28
Long-Term Leases	72.05	73.29	77.85	97.36	103.71	109.24
Other Long-Term Liabilities	2.48	2.4	5.6	1.35	3.86	24.97
Total Long-Term Liabilities	74.52	75.68	83.45	98.71	107.57	134.21
Total Liabilities	105.21	111.75	121.97	137.8	221.62	215.49
Preferred Stock	0	0	0	0	0	0
Common Stock	0.12	0.12	0.11	0.1	0.1	0.1
Additional Paid-in Capital	1,745	1,741	1,716	1,580	1,537	1,449
Accumulated Other Comprehensive Income	-0.08	0.12	0.27	0.02	-1.85	-0.76
Retained Earnings	-1,566	-1,534	-1,398	-1,212	-1,051	-769.08
Shareholders' Equity	179.71	207.18	318.73	368.42	483.94	678.84
Total Liabilities & Equity	284.92	318.94	440.69	506.22	705.56	921.46
Total Debt	76.79	77.85	85.27	103.54	109.34	114.82
Net Cash (Debt)	98.04	125.81	193.8	211.64	326.89	501.09
Net Cash Growth	-22.07%	-35.09%	-8.43%	-35.26%	-34.77%	29.95%
Net Cash Per Share	0.82	1.06	1.71	2.16	3.38	5.29
Book Value	179.71	207.18	318.73	368.42	483.94	678.84
Book Value Per Share	1.51	1.74	2.80	3.75	5.00	7.16
Tangible Book Value	179.71	207.18	318.73	368.42	483.94	678.84
Tangible Book Value Per Share	1.51	1.74	2.80	3.75	5.00	7.16

SEC Filings: 10-K · 10-Q